Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Sci Total Environ ; 887: 163636, 2023 Aug 20.
Article in English | MEDLINE | ID: mdl-37164069

ABSTRACT

Pesticide reduction is given high priority in the worldwide sustainability agenda. The reduction of pesticide impacts, rather than the reduction of application rates, has become a common criterion for monitoring policy progress. However, simplicity-an essential requirement in improving the applicability of pesticide impact assessment-may distort the accuracy of the evaluation and therefore prevent effective pesticide reduction. Here, we present contrasting results that underscore how the selection of evaluation methods that differ in simplicity affects the assessment results of pesticide reduction strategies. Briefly, we analysed the impact of conversion from conventional to low-input management adopting both a simplified linear-based method and a precise method that includes newly calculated nonlinear approach-based characterization factors for 109 active ingredients (AIs). The two methods were then used to estimate the freshwater ecotoxicity impact of eight rice farms in Japan where both conventional pesticide application and pesticide reduction strategies are practiced. The results show that the simplified method generated anomalies at the farm level through overestimation and underestimation of the individual AI impacts. Patterns that contributed to extreme changes of impact at the farm level were also identified. These findings suggest a strong need for a precise evaluation method for effectively monitoring policy progress at the farm level.


Subject(s)
Oryza , Pesticides , Pesticides/analysis , Japan , Fresh Water , Farms , Agriculture/methods
2.
Materials (Basel) ; 15(17)2022 Aug 30.
Article in English | MEDLINE | ID: mdl-36079366

ABSTRACT

This paper describes orthogonal experiments to investigat the effects of content of fly ash and slag, sol ratio, modulus of sodium silicate and expander on the compressive strength and shrinkage of alkali activated low-carbon green concrete (AAGC) of different ages. The microstructures and hydration product compositions of AAGC with different proportions were further studied by Scanning Electron Microscopy (SEM), X-ray Diffraction (XRD) and Mercury Intrusion Porosimetry (MIP). The results show that with an increase of fly ash content, the compressive strength of AAGC gradually decreases, the decline of compressive strength at 28 d is smaller than that of 7 d, and the shrinkage strain gradually increases at 28 d. As the sol ratio increases, the compressive strength increases first and then decreases. When the sol ratio is 0.42, the compressive strength is maximal at 28 d; the same is true for compressive strength at 7 d. Additionally, an increase of sol ratio can reduce the shrinkage strain at 28 d. Finally, when the sol ratio was 0.46, the shrinkage decreased by 30.5% compared with 0.40 at 28 d. As the modulus of sodium silicate (Ms) increases, the compressive strength first increases and then decreases. When Ms is 1.4, the compressive strength reaches the maximum. As Ms increases, the shrinkage strain decreases first and then increases at 28 d. When Ms is 1.0, the shrinkage strain is the maximum at 28 d. Finally, with an increase in the content of expander, the compressive strength decreases at 7 d and 28 d, and the shrinkage strain decreases at 28 d. The shrinkage strain at 28 d is the minimum with 9% content. AAGC mixed with a small amount of fly ash and expander has more hydration products and significantly reduced cracks. In addition, the proportion of small hole volume of AAGC increases, while the proportion of large hole volume decreases. AAGC mixed with fly ash and slag without expander has more unhydrated particles and its structure is loose.

3.
Gene ; 821: 146269, 2022 May 05.
Article in English | MEDLINE | ID: mdl-35150820

ABSTRACT

BACKGROUND: Bladder cancer is a malignant tumor characterized by high recurrence and persistence due to the limited therapies that are currently available. Hirudin exerts a strong anticancer effect on several tumors. Thus, it is urgent to explore the biological function of hirudin in bladder cancer and the role of bladder cancer-derived exosomes in tumor inhibition. METHODS: First, a network pharmacology analysis was performed to explore the relationships among hirudin, bladder cancer, and exosomes. Then, the effects of hirudin were examined by CCK-8 assay, flow cytometry, Transwell assay, and tumorigenic ability experiments in vitro. Exosomes derived from cells were identified with transmission electron microscopy, fluorescence labeling, and Western blotting and collected for further microarray analysis. Only CDC6 expression and mRNA abundance in hirudin-treated cells and exosomes was subjected to further validation using quantitative PCR and Western blotting. RESULTS: Through network analysis, we found that hirudin affected bladder cancer, and this effect was related to exosomes. Our studies verified the effects of hirudin by revealing that hirudin inhibits malignant processes of bladder cancer cells in vitro, such as invasion, metastasis, and apoptosis. Similarly, the oncogenic effects of bladder cancer-derived exosomes were successfully isolated and identified. Via microarray assessment of the exosomes, we identified 600 differential mRNAs, of which the expression of the core target CDC6 was found to be significantly different in both The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets. We further confirmed that hirudin suppresses CDC6 expression mRNA abundance in both cells and exosomes. CONCLUSION: Hirudin was able to decrease the expression of CDC6 in bladder cancer cells and exosomes, which effectively repressed the malignant processes of bladder cancer cells.


Subject(s)
Cell Cycle Proteins/genetics , Exosomes/genetics , Hirudins/pharmacology , Nuclear Proteins/genetics , Urinary Bladder Neoplasms/genetics , Cell Cycle Proteins/metabolism , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Down-Regulation , Exosomes/drug effects , Exosomes/metabolism , Gene Expression Regulation, Neoplastic/drug effects , Humans , Network Pharmacology/methods , Nuclear Proteins/metabolism , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder Neoplasms/metabolism
4.
Medicine (Baltimore) ; 100(30): e26809, 2021 Jul 30.
Article in English | MEDLINE | ID: mdl-34397739

ABSTRACT

ABSTRACT: Sacubitril/valsartan (sac/val) was launched in China in 2018; however, the adoption of sac/val in real-world clinical practice has yet to be described.This study aimed to analyze real-world treatment patterns of sac/val using data from 3 tertiary hospitals in China.A non-interventional, retrospective cohort study of patients with Heart failure (HF) prescribed sac/val from 3 tertiary hospitals in China between January 1, 2018 and June 30, 2020 was conducted. The analysis included sac/val dose titration patterns and persistence during 6 months post-index.A total of 267 patients were included, with a mean age of 63.9 ±â€Š13.1 years. At index, 27% of patients were prescribed sac/val 12/13 mg b.i.d., 63.7% were prescribed 24/26 mg b.i.d., 4.5% were prescribed the target dose of 49/51 mg b.i.d., and 4.8% were not prescribed according to the recommended dose. During the 6 months post-index, 8.3% of patients had only 1 dose titration record. Good therapeutic persistence was observed across sac/val doses, and only 15.7% of patients discontinued sac/val during the 6 months post-index.In China, the majority of patients prescribed sac/val are not initiated on the recommended dose nor up-titrated according to drug instruction. Notably, good persistence with sac/val is observed in the real-world cohort study.


Subject(s)
Aminobutyrates/therapeutic use , Angiotensin Receptor Antagonists/therapeutic use , Biphenyl Compounds/therapeutic use , Guideline Adherence/statistics & numerical data , Heart Failure/drug therapy , Valsartan/therapeutic use , Aged , Drug Combinations , Female , Humans , Male , Middle Aged , Retrospective Studies
5.
Sci Total Environ ; 716: 137034, 2020 May 10.
Article in English | MEDLINE | ID: mdl-32036139

ABSTRACT

Management of the negative environmental impact of pesticides used in paddy fields requires the quantification of the emissions reaching relevant environmental compartments and the determination of the factors that influence such emissions. The present study is the first to develop a simulation model for estimating the fractions emitted to the air (fair), surface water (fsw), and the fractions that leach vertically (fvl) of pesticides applied in paddy fields for life cycle assessments (LCA). The emission quantification methods are based on the properties of the active ingredients of the pesticides and management aspects such as formulations (granular or liquid) and the water-holding period following application. The emission fractions of 37 pesticides used commonly in Japan were estimated using the presented model. A sensitivity analysis was conducted by adjusting parameters applied in the model to reveal their influence on the emission fractions. The parameters influencing fair included the formulation applied, while the water-holding period and waterproofing of the levee influenced fsw regardless of the formulation adopted, suggesting that local management could effectively reduce emissions to surface water. In addition, soil organic carbon content influenced fvl greatly, suggesting considerable regional variation in the emission factor. The developed model is expected to greatly improve the realism of impact assessment of pesticide in LCAs for paddy rice cultivation, considering it fills a gap in the fate model used in LCAs to estimate pesticide emissions to air, surface water, and soil in paddy fields.

6.
Zhonghua Nan Ke Xue ; 26(11): 1025-1029, 2020 Nov.
Article in Chinese | MEDLINE | ID: mdl-34898075

ABSTRACT

OBJECTIVE: To investigate the effect of Linshu Decoction (LSD) combined with levofloxacin in the treatment of lower urinary tract symptoms in patients with type ⅢA prostatitis. METHODS: We randomly divided 124 type ⅢA prostatitis patients with lower urinary tract symptoms into an experimental and a control group, the former treated orally with LSD (1 dose bid) combined with levofloxacin tablets (0.1 g bid), and the latter with levofloxacin tablets only (0.1g bid). Before and after 4 weeks of medication, we obtained the NIH-CPSI, Traditional Chinese Medicine symptoms (TCM) scores, white blood cell (WBC) count in EPS and the results of uroflowmetry from the patients and compared them between the two groups. RESULTS: Finally 115 of the patients were included in this study. After 4 weeks of treatment, the patients of the experimental group, compared with the controls, showed significantly decreased NIH-CPSI (14.57 ± 3.87 vs 20.12 ± 3.45, P < 0.05), TCM scores (6.35 ± 1.27 vs 10.72 ± 1.72, P < 0.05) and WBC count in EPS (ï¼»7.35 ± 4.52ï¼½ vs ï¼»9.87 ± 5.87ï¼½ n/HP, P < 0.05). In comparison with baseline, the maximum urinary flow rate (Qmax) and average urinary flow rate (Qave) were increased in both of the two groups after medication, with statistically significant difference only in the experimental group (P < 0.05). CONCLUSIONS: Linshu Decoction combined with levofloxacin is more effective than levofloxacin alone in the treatment of lower urinary tract symptoms in patients with type ⅢA prostatitis.


Subject(s)
Lower Urinary Tract Symptoms , Prostatitis , Chronic Disease , Humans , Levofloxacin/therapeutic use , Lower Urinary Tract Symptoms/drug therapy , Male , Medicine, Chinese Traditional , Prostatitis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...